vertex pharmaceuticals inc
(VRTX:NASDAQ GS)
Executive Profile*
Steven J. Burakoff M.D.Member of Scientific Advisory Board, Vertex Pharmaceuticals Incorporated |
| Age | Total Calculated Compensation | This person is connected to 60 board members in 3 different organizations across 5 different industries. See Board Relationships |
| 69 | -- |
Background*
Dr. Steven J. Burakoff, MD served as the Chairman of the Department of Pediatric Oncology at Dana-Farber Cancer Institute from 1985 to 2000. Dr. Burakoff has been a Director of Genzyme Corporation since June 2010. Dr. Burakoff serves as a Member of Scientific Advisory Board at Vertex Pharmaceuticals Incorporated. He serves as a Member of Cancer Center Advisory Board at St. Jude Children's Research Hospital, Inc. Dr. Burakoff served as a Director of Ligand Pharmaceuticals ...
Corporate Headquarters*130 Waverly StreetCambridge, Massachusetts 02139-4242 United States Phone: 617-341-6100 Fax: -- Board Members Memberships*2005-2008 Former Director and Member of Compensation Committee 2008-N/A Former Director 2010-Present Director, Member of Compensation Committee and Member of Risk Oversight Committee
Education*BS Lehigh University MD Albany Medical College Master's Degree City University of New York at Queens College
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| VRTX:US | $79.49 USD | +1.60 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Richard F. Pops | Chairman and Chief Executive Officer Alkermes plc | $775.0K |
| Jean-Jacques Bienaimé | Chief Executive Officer and Director BioMarin Pharmaceutical Inc. | $821.1K |
| N. Anthony Coles M.D., M.P.H. | Chairman, Chief Executive Officer and President Onyx Pharmaceuticals, Inc. | $740.0K |
| Leonard S. Schleifer M.D., Ph.D. | Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee Regeneron Pharmaceuticals, Inc. | $3.3M |
| Bruce C. Cozadd | Co-Founder, Executive Chairman and Chief Executive Officer Jazz Pharmaceuticals Public Limited Company | $722.2K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Cambridge, MA | Vertex PharmaceuticalsPosted: May 14
- Cambridge, MA | Vertex PharmaceuticalsPosted: May 14
- Cambridge, MA | Vertex PharmaceuticalsPosted: May 14
- Cambridge, MA | Vertex PharmaceuticalsPosted: May 14
Sponsored Financial Commentaries
Sponsored Links
To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








